SPONSOR
SCG Cell Therapy Pte. Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 1, Phase 2
Conditions studied: HCCHepatitis B Virus Related Hepatocellular CarcinomaHepatocellular CarcinomaHepatocellular Carcinoma Recurrent
SCG Cell Therapy Pte. Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including HCC, Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma Recurrent.
The trial portfolio spans Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — SCG Cell Therapy Pte. Ltd.
How many clinical trials has SCG Cell Therapy Pte. Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by SCG Cell Therapy Pte. Ltd., of which 2 are actively recruiting participants. These trials cover conditions including HCC, Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does SCG Cell Therapy Pte. Ltd. research focus on?
SCG Cell Therapy Pte. Ltd. clinical trials span HCC, Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinoma Recurrent. The research pipeline includes Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a SCG Cell Therapy Pte. Ltd. clinical trial?
To participate in a SCG Cell Therapy Pte. Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all SCG Cell Therapy Pte. Ltd. trials with current recruitment status updated daily.
Clinical Trials by SCG Cell Therapy Pte. Ltd.
NCT06617000 Phase 1
Recruiting
A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
HCC
NCT05417932 Phase 1, Phase 2
Recruiting
A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
Hepatitis B Virus Related Hepatocellular Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology